中国生物制药(01177)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01177 中国生物制药

休市中 04-26 16:08:20

2.770

+0.030

+1.09%

最高2.810	最低2.720	成交量3,949万
今开2.740	昨收2.740	日振幅3.28%
总市值520.79亿	流通市值520.79亿	总股本188.01亿
成交额1.10亿	换手率0.21%	流通股本188.01亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01177","market":"HK","secType":"STK","nameCN":"中国生物制药","latestPrice":2.77,"timestamp":1714118900011,"preClose":2.74,"halted":0,"volume":39487702,"delay":0,"floatShares":18801217230,"shares":18801217230,"eps":0.13554499,"marketStatus":"休市中","marketStatusCode":7,"change":0.03,"latestTime":"04-26 16:08:20","open":2.74,"high":2.81,"low":2.72,"amount":109609806,"amplitude":0.032847,"askPrice":2.77,"askSize":1319000,"bidPrice":2.76,"bidSize":1267000,"shortable":3,"etf":0,"ttmEps":0.1355449883051922,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714354200000},"adr":0,"adjPreClose":2.74,"dividendRate":0.017677,"openAndCloseTimeList":[[1714095000000,1714104000000],[1714107600000,1714118400000]],"volumeRatio":1.009106641304254,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"SBO.HK"},"requestUrl":"/m/hq/s/01177","defaultTab":"news","newsList":[{"id":"2430123185","title":"中国生物制药(01177.HK)创新药TQA3038完成I期临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2430123185","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2430123185?lang=zh_cn&edition=full","pubTime":"2024-04-26 00:39","pubTimestamp":1714063140,"startTime":"0","endTime":"0","summary":"中国生物制药(01177.HK) 公布，集团自主研发的1类创新药“TQA3038 (siRNA)”已于近日顺利完成I期临床研究。结果显示，TQA3038具有良好的安全性和耐受性，与其他在研同类siRNA药物的安全性相似；药代动力学特征与其非临床药代特征一致。TQA3038注射液是一种靶向乙型肝炎病毒(HBV)的小干扰RNA(siRNA)药物，适应症为慢性乙型肝炎。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-25 16:25。)AASTOCKS新闻","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20220728114525438_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20220728114525438_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1345171/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2430474785","title":"中国生物制药(01177)：1类创新药“TQA3038 (siRNA)”完成I期临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2430474785","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430474785?lang=zh_cn&edition=full","pubTime":"2024-04-25 18:05","pubTimestamp":1714039536,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物制药 发布公告，集团自主研发的1类创新药“TQA3038 ”已于近日顺利完成I期临床研究。TQA3038采用具有自主知识产权的核酸序列，与目前临床进展最快的siRNA 相比，具有更强的体外及体内抗病毒活性。集团发起的“评价TQA3038在健康成年受试者中安全性、耐受性、药代动力学特征的随机、双盲、安慰剂对照的I期临床研究”已于近日顺利完成。集团将于近期启动TQA3038注射液在慢性乙型肝炎患者中的后续临床研究。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1110081.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430427790","title":"中国生物制药04月25日遭主力抛售1512万元 环比增加987.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430427790","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430427790?lang=zh_cn&edition=full","pubTime":"2024-04-25 16:16","pubTimestamp":1714032999,"startTime":"0","endTime":"0","summary":"04月25日, 中国生物制药股价涨2.24%，报收2.74元，成交金额2.48亿元，换手率0.48%，振幅5.60%，量比1.06。中国生物制药今日主力资金净流出1512万元，连续3日净流出，上一交易日主力净流出139万元，今日环比增加987.77%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为66.67%，平均跌幅为2.00%。该股近5个交易日上涨12.76%，主力资金累计净流出3796万元；近20日主力资金累计净流出6422万元，其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251617418b521d2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251617418b521d2a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430589442","title":"中国生物制药(01177)出现大手卖出82.5万股，成交价$2.79，涉资230.175万","url":"https://stock-news.laohu8.com/highlight/detail?id=2430589442","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2430589442?lang=zh_cn&edition=full","pubTime":"2024-04-25 13:03","pubTimestamp":1714021380,"startTime":"0","endTime":"0","summary":"[大手成交]中国生物制药(01177)在下午01:03出现大手卖出，成交量为82.5万，成交价为港币$2.79，涉资230.175万。至目前为止，股价升4.104%，今日最高价为$2.81，而最低价为$2.66，总成交量为5.972千万股，总成交金额港币$1.646亿。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180416150431576_s.png","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180416150431576_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2404255042/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2429410652","title":"中国生物制药(01177)出现大手买入140万股，成交价$2.66，涉资372.4万","url":"https://stock-news.laohu8.com/highlight/detail?id=2429410652","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2429410652?lang=zh_cn&edition=full","pubTime":"2024-04-24 13:00","pubTimestamp":1713934800,"startTime":"0","endTime":"0","summary":"[大手成交]中国生物制药(01177)在下午01:00出现大手买入，成交量为140万，成交价为港币$2.66，涉资372.4万。至目前为止，股价升3.101%，今日最高价为$2.68，而最低价为$2.58，总成交量为3.041千万股，总成交金额港币$8.021千万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180416150431576_s.png","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180416150431576_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2404243778/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2429121280","title":"中国生物制药(01177.HK)获主席谢其润增持200万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2429121280","media":"港股那点事","top":-1,"share":"https://www.laohu8.com/m/news/2429121280?lang=zh_cn&edition=full","pubTime":"2024-04-24 07:35","pubTimestamp":1713915343,"startTime":"0","endTime":"0","summary":"格隆汇4月24日丨根据联交所最新权益披露资料显示，2024年4月23日，中国生物制药(01177.HK)获执行董事兼主席谢其润在场内以每股均价2.5891港元增持200万股，涉资约517.82万港元。增持后，谢其润最新持股数目为600万股，持股比例由0.02%上升至0.03%。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-24/doc-inaswpfk8950983.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-24/doc-inaswpfk8950983.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429245139","title":"中国生物制药(01177)出现大手买入180万股，成交价$2.59，涉资466.2万","url":"https://stock-news.laohu8.com/highlight/detail?id=2429245139","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2429245139?lang=zh_cn&edition=full","pubTime":"2024-04-23 11:30","pubTimestamp":1713843000,"startTime":"0","endTime":"0","summary":"[大手成交]中国生物制药(01177)在上午11:30出现大手买入，成交量为180万，成交价为港币$2.59，涉资466.2万。至目前为止，股价升1.181%，今日最高价为$2.59，而最低价为$2.51，总成交量为1.741千万股，总成交金额港币$4.445千万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180126132515779_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180126132515779_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2404233157/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2429613900","title":"中国生物制药(01177.HK)获执行董事谢承润增持500万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2429613900","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2429613900?lang=zh_cn&edition=full","pubTime":"2024-04-23 06:48","pubTimestamp":1713826086,"startTime":"0","endTime":"0","summary":"格隆汇4月23日丨根据联交所最新权益披露资料显示，2024年4月19日，中国生物制药(01177.HK)获执行董事谢承润在场内以每股均价2.3239港元增持500万股，涉资约1161.95万港元。增持后，谢承润最新持股数目为4,055,000,000股，持股比例由21.54%上升至21.57%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404230648178b47ab61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404230648178b47ab61&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429949756","title":"大涨近9% 中国生物制药大股东增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2429949756","media":"证券时报网","top":-1,"share":"https://www.laohu8.com/m/news/2429949756?lang=zh_cn&edition=full","pubTime":"2024-04-22 18:31","pubTimestamp":1713781860,"startTime":"0","endTime":"0","summary":"证券时报e公司讯，4月22日，港股三大指数全线收高，科技、医药股走强。中国生物制药以近9%的涨幅领涨当天生物医药股，石药集团、复星医药、信达生物分别上涨3.99%、3.32%、2.26%。当天盘后，香港联交所披露文件显示，中国生物制药第一大股东、公司CEO谢承润于4月19日以每股均价2.32港元增持中国生物制药500万股普通股股份，价值约1161.95万港元。增持后，谢承润最新持股数目为40.55亿股股份，好仓比例由21.54%升至21.57%。联交所文件还显示，4月19日，中国生物制药董事会主席谢其润也在场内以每股均价2.32港元增持250万股，涉资约580.58万港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221832178b45c914&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221832178b45c914&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429962187","title":"中国生物制药大涨超7%，恒生医药ETF涨超3%！","url":"https://stock-news.laohu8.com/highlight/detail?id=2429962187","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2429962187?lang=zh_cn&edition=full","pubTime":"2024-04-22 10:12","pubTimestamp":1713751960,"startTime":"0","endTime":"0","summary":"中国生物制药研发的1类创新药即将递交上市申请，中国生物制药盘中一度大涨超7%，再鼎医药、信达生物、百济神州等集体反攻，恒生医药ETF（159892）一度涨超3%，持仓股多数上涨。在跟踪恒生生物科技指数（HSHKBIO）的A股ETF中，恒生医药ETF规模最大，成交额排名第一，支持T+0交易且流动性良好。当前指数的PS估值处于历史底部，具备一定的安全边际。每日经济新闻","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240422101350879eef59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240422101350879eef59&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429564962","title":"港股三大指数均涨超2% 中国生物制药涨近6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429564962","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2429564962?lang=zh_cn&edition=full","pubTime":"2024-04-22 10:08","pubTimestamp":1713751702,"startTime":"0","endTime":"0","summary":"每经AI快讯，4月22日，港股三大指数均涨超2%，中国生物制药涨近6%领涨蓝筹，京东集团、新奥能源涨5%。科技股方面，商汤涨超5%，网易、美团、心动公司涨超4%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202404223053937615.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202404223053937615.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429964425","title":"中国生物制药(01177)出现大手买入75.7万股，成交价$2.47，涉资186.979万","url":"https://stock-news.laohu8.com/highlight/detail?id=2429964425","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2429964425?lang=zh_cn&edition=full","pubTime":"2024-04-22 09:55","pubTimestamp":1713750900,"startTime":"0","endTime":"0","summary":"[大手成交]中国生物制药(01177)在上午09:55出现大手买入，成交量为75.7万，成交价为港币$2.47，涉资186.979万。至目前为止，股价升5.556%，今日最高价为$2.49，而最低价为$2.41，总成交量为2.3千万股，总成交金额港币$5.571千万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180815142908460_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180815142908460_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2404222161/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2429096624","title":"港股异动 | 中生制药(01177)现涨超5% 创新药罗伐昔替尼片关键注册研究达主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2429096624","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429096624?lang=zh_cn&edition=full","pubTime":"2024-04-22 09:33","pubTimestamp":1713749616,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中生制药现涨超5%，截至发稿，涨4.7%，报2.45港元，成交额2714.65万港元。消息面上，中国生物制药公布，集团自主研发的1类创新药罗伐昔替尼片“Rovadicitinib ”用于治疗中高危骨髓纤维化的关键注册临床研究已达主要终点。该行相信，这反映中生制药的商业能力得到跨国公司的高度认可。汇丰预计，中生制药在新药上市和业务前景可观支持下得到持续增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1106277.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429969373","title":"中国生物制药盘中异动 股价大涨5.13%报2.461港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429969373","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429969373?lang=zh_cn&edition=full","pubTime":"2024-04-22 09:32","pubTimestamp":1713749560,"startTime":"0","endTime":"0","summary":"2024年04月22日早盘09时32分，中国生物制药股票出现异动，股价急速上涨5.13%。中国生物制药股票所在的药品行业中，整体跌幅为0.08%。消息层面，截至09时32分，中国生物制药股票正面舆情新闻比例25%。该信息摘要如下：4月19日报道，根据香港联交所4月19日披露的文件，谢其润于4月19日以每股均价2.3223港元增持$中国生物制药 $250万股普通股股份，价值约580.57万港元。增持后，谢其润最新持股数目为400万股股份，好仓比例由0.01%升至0.02%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404220932427a5459b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404220932427a5459b6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429696966","title":"中国生物制药4月19日获南向资金加仓1345.70万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2429696966","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429696966?lang=zh_cn&edition=full","pubTime":"2024-04-22 09:31","pubTimestamp":1713749473,"startTime":"0","endTime":"0","summary":"4月19日, 南向资金增持中国生物制药1345.70万股。截止当日收盘，港股通共持有中国生物制药198177.49万股，占流通股10.53%。港股通增持金额前五个股分别为腾讯控股、中国移动、建设银行、中国银行、中广核电力。中国生物制药近5个交易日下跌14.29%，港股通累计增持3143.72万股；近20个交易日下跌25.71%，港股通累计增持13003.68万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404220942018b43b6f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404220942018b43b6f2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428063187","title":"中国生物制药(01177)：受托人根据限制性股份奖励计划进一步购买500万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2428063187","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428063187?lang=zh_cn&edition=full","pubTime":"2024-04-19 18:11","pubTimestamp":1713521480,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物制药(01177)发布公告，于2024年4月19日，受托人从市场进一步购买500万股股份，并根据计划规则的条款及条件代获选参与者以信托持有。每股股份平均代价约2.339港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1105500.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2428333706","title":"中国生物制药(01177)4月19日斥资1168.2万港元回购500万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2428333706","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428333706?lang=zh_cn&edition=full","pubTime":"2024-04-19 17:04","pubTimestamp":1713517484,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物制药(01177)发布公告，于2024年4月19日该公司斥资1168.2万港元回购500万股，回购价格为每股2.32-2.34港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1105392.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2428577272","title":"中国生物制药盘中异动 早盘快速下挫5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428577272","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428577272?lang=zh_cn&edition=full","pubTime":"2024-04-19 10:41","pubTimestamp":1713494489,"startTime":"0","endTime":"0","summary":"2024年04月19日早盘10时41分，中国生物制药股票出现异动，股价急速下挫5.39%。截至发稿，该股报2.300港元/股，成交量3921.36万股，换手率0.21%，振幅5.35%。中国生物制药股票所在的药品行业中，整体跌幅为0.28%。其相关个股中，中生联合、培力农本方、精优药业涨幅较大，振幅较大的相关个股有三爱健康集团、君圣泰医药-B、中国同辐，振幅分别为10.00%、9.29%、6.81%。中国生物制药公司简介：中国生物制药有限公司是一间主要从事药品业务的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419104129861e7552&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419104129861e7552&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428251730","title":"中国生物制药(01177.HK)创新药罗伐昔替尼片关键注册研究达主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2428251730","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2428251730?lang=zh_cn&edition=full","pubTime":"2024-04-19 01:08","pubTimestamp":1713460080,"startTime":"0","endTime":"0","summary":"中国生物制药(01177.HK) 公布，集团自主研发的1类创新药罗伐昔替尼片“Rovadicitinib(TQ05105)”用于治疗中高危骨髓纤维化的关键注册临床研究已达主要终点。集团将于近期递交TQ05105片的上市申请。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-18 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20220728114526454_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20220728114526454_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1343409/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2428562237","title":"中国生物制药(01177)：1类创新药罗伐昔替尼片“ROVADICITINIB (TQ05105)”关键注册研究取得阳性结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2428562237","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428562237?lang=zh_cn&edition=full","pubTime":"2024-04-18 19:35","pubTimestamp":1713440100,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物制药 发布公告，该集团自主研发的1类创新药罗伐昔替尼片“Rovadicitinib ”用于治疗中高危骨髓纤维化 的关键注册临床研究已达到主要终点。集团将于近期递交TQ05105片的上市申请。该集团于2023年美国血液学年会公布了TQ05105用于治疗骨髓增殖性肿瘤的I期临床研究数据。集团在骨髓纤维化领域还布局了多项联合研究，如TQ05105联合BET抑制剂或BCL-2抑制剂，用于治疗中高危骨髓纤维化的临床研究，初步结果较为积极。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1104781.html","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinobiopharm.com","stockEarnings":[{"period":"1week","weight":0.1709},{"period":"1month","weight":-0.0897},{"period":"3month","weight":-0.0519},{"period":"6month","weight":-0.0616},{"period":"1year","weight":-0.3462},{"period":"ytd","weight":-0.2104}],"compareEarnings":[{"period":"1week","weight":0.088},{"period":"1month","weight":0.0768},{"period":"3month","weight":0.1065},{"period":"6month","weight":0.0145},{"period":"1year","weight":-0.1103},{"period":"ytd","weight":0.0354}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"中国生物制药有限公司是一家主要从事药品业务的投资控股公司。该公司通过三个业务分部进行运营。中药现代制剂及西药分部从事生产、销售及配销中药现代制剂产品及西药产品业务。投资分部从事长期及短期投资业务。其他分部主要从事研发活动、向第三方提供服务以及从事相关医疗及医院业务。该公司还通过其子公司从事持有物业、销售健康食品、验光配镜以及零售与批发视光和听力产品业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.009982},{"month":2,"riseRate":0.666667,"avgChangeRate":0.059578},{"month":3,"riseRate":0.571429,"avgChangeRate":0.043859},{"month":4,"riseRate":0.47619,"avgChangeRate":0.026035},{"month":5,"riseRate":0.7,"avgChangeRate":0.038371},{"month":6,"riseRate":0.35,"avgChangeRate":0.003696},{"month":7,"riseRate":0.6,"avgChangeRate":0.029101},{"month":8,"riseRate":0.35,"avgChangeRate":-0.023106},{"month":9,"riseRate":0.35,"avgChangeRate":-0.024746},{"month":10,"riseRate":0.6,"avgChangeRate":0.036433},{"month":11,"riseRate":0.55,"avgChangeRate":0.076694},{"month":12,"riseRate":0.45,"avgChangeRate":-0.005852}],"exchange":"SEHK","name":"中国生物制药","nameEN":"SINO BIOPHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中国生物制药(01177)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中国生物制药(01177)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中国生物制药,01177,中国生物制药股票,中国生物制药股票老虎,中国生物制药股票老虎国际,中国生物制药行情,中国生物制药股票行情,中国生物制药股价,中国生物制药股市,中国生物制药股票价格,中国生物制药股票交易,中国生物制药股票购买,中国生物制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中国生物制药(01177)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中国生物制药(01177)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}